SEC Form 3 · accession 0001209191-18-054733
Allogene Therapeutics, Inc. · ALLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Thomas Schmidt
Officer — Chief Financial Officer
Period of report
Oct 10, 2018
Accepted (ET)
Oct 10, 2018 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001737287
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,464,750 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.